相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bexarotene Enhances Macrophage Erythrophagocytosis and Hematoma Clearance in Experimental Intracerebral Hemorrhage
Che-Feng Chang et al.
STROKE (2020)
Trimesic acid-Theophylline and Isopthalic acid-Caffeine Cocrystals: Synthesis, Characterization, Solubility, Molecular Docking, and Antimicrobial Activity
Olufunso O. Abosede et al.
CRYSTAL GROWTH & DESIGN (2020)
Quantitative Prediction of Oral Bioavailability of a Lipophilic Antineoplastic Drug Bexarotene Administered in Lipidic Formulation Using a Combined In Vitro Lipolysis/Microsomal Metabolism Approach
Jong Bong Lee et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
Julius Pollinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cocrystals of Leflunomide: Design, Structural, and Physicochemical Evaluation
Joseph Cadden et al.
CRYSTAL GROWTH & DESIGN (2019)
Investigation of the Phase Behavior of a HNIW•TNT Cocrystal System and Construction of Ternary Phase Diagrams
Qian Jia et al.
CRYSTAL GROWTH & DESIGN (2019)
The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals
Shuzhen Ren et al.
ACTA PHARMACEUTICA SINICA B (2019)
Hydrates and Solvates of Acotiamide Hydrochloride: Crystallization, Structure, Stability, and Solubility
Guoshun Zhang et al.
CRYSTAL GROWTH & DESIGN (2019)
Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects
Wenxia Cui et al.
AAPS PHARMSCITECH (2019)
Ethinyl estradiol cocrystals assembled by chain structures: improvement in stability and solubility
Rongkai Du et al.
NEW JOURNAL OF CHEMISTRY (2019)
Ligustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia
Tengfei Zhao et al.
IUBMB LIFE (2018)
Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer
Luxi Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPAR gamma/PTEN/mTOR signaling pathway
Xinghao Ai et al.
BMC CANCER (2018)
Crystallizing Ionic Cocrystals: Structural Characteristics, Thermal Behavior, and Crystallization Development of a Piracetam-CaCl2 Cocrystallization Process
Lixing Song et al.
CRYSTAL GROWTH & DESIGN (2018)
Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives
Jinmi Zou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Oral bioavailability enhancement of beta-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion
Chengyu Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Curcumin Cocrystal Micellesd-Multifunctional Nanocomposites for Management of Neurodegenerative Ailments
Preshita P. Desai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Tetramethylpyrazine Protects Against Early Brain Injury and Inhibits the PERK/Akt Pathway in a Rat Model of Subarachnoid Hemorrhage
Zhengkai Shao et al.
NEUROCHEMICAL RESEARCH (2018)
Bexarotene attenuates early brain injury via inhibiting micoglia activation through PPAR after experimental subarachnoid hemorrhage
Li Tu et al.
NEUROLOGICAL RESEARCH (2018)
Entacapone: Improving Aqueous Solubility, Diffusion Permeability, and Cocrystal Stability with Theophylline
Manish Kumar Bommaka et al.
CRYSTAL GROWTH & DESIGN (2018)
A New 1:1 Drug-Drug Cocrystal of Theophylline and Aspirin: Discovery, Characterization, and Construction of Ternary Phase Diagrams
Shaza Darwish et al.
CRYSTAL GROWTH & DESIGN (2018)
Borneol and -asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors
Jun-Yong Wu et al.
DRUG DELIVERY (2018)
Development of New Bexarotene-loaded Mesoporous Silica Systems for Topical Pharmaceutical Formulations
Aurelia Vasile et al.
ACTA CHIMICA SLOVENICA (2018)
Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post-ischaemic neuroregeneration and recovery of neurological functions in rats
Gaoxiao Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
New Cocrystals of Hydrochlorothiazide: Optimizing Solubility and Membrane Diffusivity
Shanmukha Prasad Gopi et al.
CRYSTAL GROWTH & DESIGN (2017)
Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer
Yongjie Wang et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal
Sunil Kumar Nechipadappu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Taming photo-induced oxidation degradation of dihydropyridine drugs through cocrystallization
Qihui Yu et al.
CHEMICAL COMMUNICATIONS (2017)
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
Paolo Cerreia Vioglio et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
A melt castable energetic cocrystal
Jonathan C. Bennion et al.
CHEMICAL COMMUNICATIONS (2017)
Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability
Bingqing Zhu et al.
CRYSTAL GROWTH & DESIGN (2017)
Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine
Bingqing Zhu et al.
CRYSTAL GROWTH & DESIGN (2016)
Drug-drug co-crystallization presents a new opportunity for the development of stable vitamins
Jian-Rong Wang et al.
CHEMICAL COMMUNICATIONS (2016)
Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA
Jin-Chul Heo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Cocrystals of Ethenzamide: Study of Structural and Physicochemical Properties
Vijaya M. Hariprasad et al.
CRYSTAL GROWTH & DESIGN (2016)
Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor
Chenguang Wang et al.
CRYSTAL GROWTH & DESIGN (2016)
Improving the Solubility and Bioavailability of Apixaban via Apixaban-Oxalic Acid Cocrystal
Yong Chen et al.
CRYSTAL GROWTH & DESIGN (2016)
A Screening Approach for the Discovery of Mechanochromic Gold(I) Isocyanide Complexes with Crystal-to-Crystal Phase Transitions
Tomohiro Seki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain
Tabassum Khan et al.
MOLECULAR PHARMACEUTICS (2016)
Spring and parachute: How cocrystals enhance solubility
Dhara D. Bavishi et al.
PROGRESS IN CRYSTAL GROWTH AND CHARACTERIZATION OF MATERIALS (2016)
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates
Li Li et al.
DRUG DELIVERY (2016)
Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation
Lijiang Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Nuclear Quadrupole Resonance Investigation of Hydrogen Bonding in Some Cocrystals of 2,3,5,6-Tetramethylpyrazine and Carboxylic Acids
Janez Seliger et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
A nanoporous two-dimensional polymer by single-crystal-to-single-crystal photopolymerization
Patrick Kissel et al.
NATURE CHEMISTRY (2014)
Preparation, Characterization, and Evaluation of Dipfluzine-Benzoic Acid Co-crystals with Improved Physicochemical Properties
Yulong Lin et al.
PHARMACEUTICAL RESEARCH (2014)
Solubility Advantage of Tenoxicam Phenolic Cocrystals Compared to Salts
Geetha Bolla et al.
CRYSTAL GROWTH & DESIGN (2013)
Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease
Mingfei Zeng et al.
FITOTERAPIA (2013)
Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility
Sarah J. Bethune et al.
CRYSTAL GROWTH & DESIGN (2009)
Solubility Advantage of Pharmaceutical Cocrystals
David J. Good et al.
CRYSTAL GROWTH & DESIGN (2009)
Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats
Xiao-Ling Zhu et al.
NEUROSCIENCE LETTERS (2009)
At decision-support tool for the formulation of orally active, poorly soluble compounds
Sebastien Branchu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Cocrystals of piroxicam with carboxylic acids
Scott L. Childs et al.
CRYSTAL GROWTH & DESIGN (2007)
Supramolecular synthon polymorphism in 2 : 1 co-crystal of 4-hydroxybenzoic acid and 2,3,5,6-tetramethylpyrazine
B. R. Sreekanth et al.
CHEMICAL COMMUNICATIONS (2007)
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
C. Assaf et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Synthesis, crystal structure analysis, and pharmacological characterization of disila-bexarotene, a disila-analogue of the RXR-selective retinoid agonist bexarotene
JO Daiss et al.
ORGANOMETALLICS (2005)
Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids
BR Haugen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
分享论文
